Pressmeddelande Publicerat: 2015-04-17 15:50:00

AktieTorget: EQL Pharma’s 2014 Annual Report now available

Today, EQL Pharma announced that the company’s Annual Report for 2014 is available as PDF at www.eqlpharma.com. For more information, please contact: Christer Fåhraeus CEO EQL Pharma AB Phone: +46 (0) 705 – 60 90 00 E-mail: christer.fahraeus@eqlpharma.com Website: www.eqlpharma.com EQL Pharma AB in short EQL Pharma is a Swedish pharmaceutical company specialised in development and sales of generics, i.e. pharmaceuticals that are medically equivalent to original pharmaceuticals. The company is currently focused on prescription medicines in the Nordic countries where the competitive pressure is low or absent, i.e. niche generics. The products are manufactured both in Europe, India and China, but always meeting the European standard and quality. The financial target for the company is to be profitable as of 2015. EQL Pharma’s registered office is in Lund, Sweden. The share is listed on AktieTorget. Read more at www.eqlpharma.com.

Dokument

EQL Pharma AB

"EQL Pharma är specialiserat på att utveckla och sälja generika, det vill säga läkemedel som är likvärdiga med originalläkemedel vars patent har löpt ut. Bolaget har en basportfölj innehållande 15 produkter och en produktlinje som till och med 2015 omfattar åtta "first-in-class generics" (generika utan ytterligare konkurrenter utöver originalläkemedlet)."

Stortorget 1,
226 60 LUND
+46 46 12 01 70 http://www.eqlpharma.com